IDT Management
From right to left: Shareholder Carsten Klocke,
CEO Dr. Jürgen Betzing, Shareholder Stefan Klocke
IDT Biologika is a company of enduring strength, which we recognized with 100th-year anniversary celebrations in 2021. We are privileged to play a role in development and manufacture of the world’s leading vaccines, viral vectors, and therapeutics, which play an ongoing vital role in protecting people and improving quality of life for millions around the world. IDT Biologika has navigated 100 years and continues to bring value to customers as a result of our exceptional people.
Corporate Leadership Team
Dr. Jürgen Betzing
Chief Executive Officer
Dr. Jürgen Betzing brings with him more than 20 years of experience in business administration in the pharmaceutical industry. He received a degree in Pharmaceutical Technology from the University of Freiburg, with a qualification as Specialized Pharmacist, and holds a Business Administration degree from St. Gallen Business School.
Dr. Ulrich Valley
Chief Operations Officer / Managing Director
Dr. Ulrich Valley has many years of experience in the pharmaceutical industry and has held various management positions with a focus on Technical Operations, Supply Chain and Development.
He holds a Ph.D. in Biotechnology from the University Of Braunschweig (Germany), where he also received his diploma.
Prof. Dr. Ulrike Fiedler
Chief Commercial Officer
Dr. Ulrike Fiedler is Chief Commercial Officer at IDT Biologika. Ulrike has been with IDT Biologika since 2014, bringing her 28 years of biotech experience as well as entrepreneurial responsibility and science-based innovation to the role. Ulrike studied Biochemistry at the Martin-Luther-University Halle-Wittenberg, where she also received her doctor’s degree and has also been an Honorary Professor for Industrial Biotechnology since 2015.
Jürgen Kulbe
Chief Finance Officer
Jürgen Kulbe is Chief Financial Officer at IDT Biologika, responsible for Finance, IT, and Human Resources across all sites. He has held positions with global responsibility in various industry segments and has worked in the pharma industry for the last four years. Jürgen received his degree in Business Administration from Pforzheim University of Applied Science, with a focus on Accounting and Controlling, and received his Executive MBA from the University of St. Gallen.
Dr. Björn Riedel
Senior Vice President Quality
Björn Riedel leads the Quality Unit at IDT Biologika as the Chief Quality Officer. He has more than 19 years of experience in the manufacturing, testing, and quality management of vaccines and other drug products. By training, Björn is a graduated biologist, with a specialization in microbiology, genetics, biochemistry, and biotechnology, and is a registered European qualified person for human vaccines.
Dr. Simone Kardinahl
Vice President Development
Simone Kardinahl is Vice President of Development and has over 20 years of experience in the pharmaceutical industry, having held different positions in Research, Development, and Manufacturing of Biologics products. She studied Biochemistry at the University of Hannover and received her doctor’s degree in Biochemistry from the University of Lübeck.
North American Operations
Dr. Manoj Menon
Managing Director
Dr. Manoj Menon has over 20 years of experience in the biopharma industry in biologics product development and commercial launches, establishment of global product supply chains, contract manufacturing, international technology transfers, and manufacturing facility validation. He holds a Ph.D. in Chemical Engineering from the University of Delaware, and Bachelors/Masters in Biochemical Engineering and Biotechnology from Indian Institute of Technology, New Delhi.
Dr. Heidi Trusheim
Senior Director, Process Development
Heidi Trusheim is Senior Director, Process Development at IDT Biologika. As a scientist, Heidi has expertise in developing, overseeing, and validating processes to manufacture and commercialize novel biological products. She has over 20 years of experience in research and development, with 15 years in the biopharmaceutical industry. Heidi received her doctor’s degree and M.Sc. from the University of Osnabrück.
Dr. Ajay Bhale
Vice President Quality
Dr. Ajay Bhale is Vice President of Quality and has over 30 years of biopharmaceutical manufacturing, testing, and quality management experience. He received his Ph.D. in chemistry from DAVV (Indore University), India, and conducted post-doctoral research work at Kagoshima University, Japan, the University of New Mexico, and the University of Kansas, USA.